Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Clinical Nephrology. Case Studies|October 19, 2017
Collapsing glomerulopathy associated with hemophagocytic syndrome in a patient with NK/T cell lymphomaWihib Gebregeorgis, Inder Patel, Manish Thakur, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2026
Use of CD38 Antibodies in High-Risk Newly Diagnosed Multiple Myeloma: A Meta-AnalysisDivaya Bhutani, Yusha Liu, Rajshekhar Chakraborty, et al.
International Journal of Cancer|February 2, 2021
Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal proteinRouslan Kotchetkov, David Susman, Divaya Bhutani, et al.
American Journal of Ophthalmology Case Reports|March 31, 2021
Asymmetric optic disc edema in a young patient with POEMS: A rare presentation of a rare diseaseHana Mahallati, James Kirkland Roberts, Amer Assal, et al.
The American Journal of Cardiology|August 30, 2008
Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndromeRussell Stein, Bhanu Gupta, Sanjay Agarwal, et al.
British Journal of Haematology|September 6, 2024
Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition diseaseDivaya Bhutani, Yusha Liu, Rajshekhar Chakraborty, et al.
European Journal of Haematology|February 5, 2025
Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific AntibodyDivaya Bhutani, Rajshekhar Chakraborty, Karan Wats, et al.
European Journal of Haematology|February 24, 2025
Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma TherapiesMichael Sang Hughes, Metodi Balev, Jai Radhakrishnan, et al.
Blood|October 9, 2020
Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myelomaShirong Li, Jing Fu, Jun Yang, et al.
British Journal of Haematology|March 10, 2023
First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapyRajshekhar Chakraborty, Cara Rosenbaum, Gurbakhash Kaur, et al.
Pageof 7